Deltex Medical Group PLC
22 May 2007
Deltex Medical Group plc
Additional Listing
Deltex Medical Group plc (the 'Company') was notified on 21 May 2007 that
certain of its European distributors have acquired 800,000 ordinary shares of 1p
each at a price of 17.50 pence per share as the result of the exercise of an
option over 800,000 shares granted on 15 December 2005.
Accordingly, application has been made for these shares to be admitted to
trading on the AIM. The shares will rank pari passu with the existing issued
shares of the Company and dealings are expected to commence on 25 May 2007.
Following this, the total number of voting rights in issue will be 84,098,441.
22 May 2007
Enquiries:
Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman
Andy Hill, Chief Executive
Ewan Phillips, Finance Director
Charles Stanley Securities 0207 149 6000
Philip Davies
Gavin Anderson
Deborah Walter/Marie Cairney/Jodie Reilly 0207 554 1400
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.